125104-19-0

Basic information

• Product Name: (±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate
• Synonyms: (±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate
• CAS NO: 125104-19-0
• Molecular Weight: 291.304
• Mol File: 125104-19-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: (±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate(125104-19-0)
• EPA Substance Registry System: (±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate(125104-19-0)

Safety Data

• Hazardous Substances Data: 125104-19-0(Hazardous Substances Data)

Usage

General Description

(±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate is a chemical compound that belongs to the class of piperidine derivatives. It is a white solid that is often used as an intermediate in the synthesis of various pharmaceutical compounds. (±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate has potential applications in drug development and medicinal chemistry, particularly in the synthesis of molecules with biological activity. The presence of a benzyloxycarbonyl group in the structure can provide protection to certain functional groups during chemical reactions, making it a versatile building block in organic synthesis. Additionally, the presence of the piperidine ring in the molecule can confer biological properties to the compounds derived from it, such as antiviral, antifungal, and analgesic activities. Therefore, this compound holds promise in the field of drug discovery and development.

Upstream product

• 79-37-8 oxalyl dichloride 
• 847029-99-6 1-benzyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate 
• 501-53-1 benzyl chloroformate 
• 144913-66-6 4-hydroxy-2-piperidine carboxylic acid methyl ester 
• 125104-17-8 2-Methyl 1-(phenylmethyl) 3,4-dihydro-4-oxo-1,2(2H)-pyridinedicarboxylate 
• 187753-15-7 methyl 4-oxopiperidine-2-carboxylate 

Downstream Products

• 1001857-31-3 1-benzyl 2-methyl 4-(benzylamino)piperidine-1,2-dicarboxylate 
• 1259011-96-5 (±)-methyl 1-benzyloxycarbonyl-4,4-difluoropiperidine-2-carboxylate 
• 1255666-28-4 1-tert-butyl 2-methyl 4,4-difluoropiperidine-1,2-dicarboxylate 
• 845256-73-7 benzyl 4-[(tert-Butoxycarbonyl)(methyl)amino]-2-(hydroxymethyl)piperidine-1-carboxylate 
• 1259012-00-4 tert-butyl 2-((2-(5-chloro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-ylamino)methyl)-4,4-difluoropiperidine-1-carboxylate 
• 1259011-99-8 (±) tert-butyl 2-(aminomethyl)-4,4-difluoropiperidine-1-carboxylate 
• 138154-97-9 8-<(3,4-dichlorophenyl)acetyl>-7-(1-pyrrolidinylmethyl)-1,4-dioxa-8-azaspiro<4.5>decane 
• 125104-53-2 cis-1-<(3,4-dichlorophenyl)acetyl>-4-hydroxy-2-(1-pyrrolidinylmethyl)piperidine 
• 125104-53-2 trans-1-<(3,4-dichlorophenyl)acetyl>-4-hydroxy-2-(1-pyrrolidinylmethyl)piperidine 
• 125104-48-5 1-<(3,4-dichlorophenyl)acetyl>-4-oxo-2-(1-pyrrolidinylmethyl)piperidine 
• 125104-47-4 1-<(3,4-dichlorophenyl)acetyl>-4-oxo-2-(1-pyrrolidinylmethyl)piperidine hydrochloride 
• 125130-50-9 8-<(3,4-dichlorophenyl)acetyl>-7-(1-pyrrolidinylmethyl)-1,4-dithia-8-azaspiro<4.5>decane 
• 125104-21-4 7-methyl 8-(phenylmethyl) 1,4-dioxa-8-azaspiro<4.5>decane-7,8-dicarboxylate 

Relevant articles and documents

Inhibitors of influenza viruses replication

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

PHENOXYETHYL CYCLIC AMINE DERIVATIVES AND THEIR ACTIVITY AS EP4 RECEPTOR MODULATORS

The present invention provides a compound of the Formula (I): wherein X, R, R1,R2,R3, R4,R5,R6, R7, R8, and R9 are as defined herein, or a pharmaceutically acceptable salt thereof.

BRIDGED DIAZEPAN OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to bridged diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. T